Imperial College London Featured PhD Programmes
Imperial College London Featured PhD Programmes
The Chinese University of Hong Kong Featured PhD Programmes

Queen’s University Belfast Pharmacy / Pharmaceutics PhD Projects, Programs & Scholarships

We have 27 Queen’s University Belfast Pharmacy / Pharmaceutics PhD Projects, Programs & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

Queen’s University Belfast

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 27 Queen’s University Belfast Pharmacy / Pharmaceutics PhD Projects, Programs & Scholarships

Long-acting microneedle delivery systems

A key trend in the pharmaceutical industry is currently long-acting drug delivery. Here, instead of taking tablets daily, a patient receives an injection or implant that contains weeks or months of medication. Read more

Electrospun Nanofibers for the Delivery of Biopharmaceuticals

The aim of this project is to investigate the use of both solution and melt based electrospinning methods for the manufacture of oral films and scaffolds for wound healing by incorporating biologic drugs (e.g. Read more

Development of lipid-based nanocarriers using melt extrusion for oral peptide delivery

Peptide-based drugs are an important class of medicine used for the treatment of many relevant disorders. However, their delicate physicochemical characteristics, poor membrane permeability and harsh conditions along the gastro-intestinal tract pose hurdles in providing effective therapy. Read more

Microfluidics in Nanomedicine

Progress in drug design has led to the development of new molecules. However, the limited ability to selectively deliver these molecules at well-defined dosing regimens remains a significant challenge. Read more

Selective targeting of proteases for the treatment of chronic airways disease.

Cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are both progressive airways diseases associated with cycles of infection and inflammation, lung tissue destruction and pulmonary decline. Read more

SMART Nanocarriers for Cancer

An important limitation in the treatment of cancer with therapeutics is the inability to achieve therapeutically effective local drug concentrations avoiding healthy tissue damage. Read more

Development of precisely engineered nanocrystals for selective tissue targeting

A considerable number of infectious diseases affect the lymphatic system and are difficult to treat because the pathogens that cause them can form reservoirs in such tissues, where current treatments can not provide sufficient concentrations of the active to eradicate these microorganisms. Read more

To investigate the pharmacological responses of senolytics in cancer

Chemotherapy causes cancer cells to become senescent and increased resistance to standard-of-care cancer therapies. Senescent cells stop dividing but remain metabolically active. Read more

Filtering Results